Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MediciNova dropping MN-305 for insomnia

MediciNova (MNOV; Osaka:4875) said it will discontinue development of MN-305 for insomnia after the

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE